FZD4 and early-onset autosomal dominant Alzheimer disease: In addition, therapeutic activation of FZD4 could also be beneficial in other vascular diseases of the CNS—such as stroke, traumatic brain injury, multiple sclerosis and Alzheimer’s disease—where endothelial cell barrier dysfunction is proposed to contribute to disease initiation and/or progression.